SKYX Positions to Advance its Market Penetration with the AI Native E-Commerce Platform Designed to Elevate B2B and B2C Experiences Through its Innovative and Smart Product Line SKYX Continues to Grow its Builder Segment Through Direct Sales Channels and Intends to Utilize the New AI Driven Software to Enhance and… Read More..

Representative Data for Systemic Tregs and Immunomodulation Credit: Coya Therapeutics, Inc. COYA 303 is an investigational proprietary biologic combination of low-dose (LD)-IL-2 and GLP-1 receptor agonist (RA) for subcutaneous administration with potential for treating inflammation-driven diseases like Alzheimer's Disease, and other neurodegenerative and autoimmune diseases COYA 303 significantly reduced peripheral… Read More..

NEW YORK, Oct. 29, 2025 (GLOBE NEWSWIRE) -- AtlasClear Holdings, Inc. (NYSE American: ATCH) (“AtlasClear” or the “Company”), a technology-enabled financial services platform modernizing trading, clearing, settlement, and banking, today announced that it will present at the ThinkEquity Conference being held at the Mandarin Oriental, New York on Thursday, October… Read More..